Pharmacy Benefit Services adjusted revenue growth measures year-over-year growth in issuer-defined adjusted revenue from the pharmacy benefit operating segment.
Evernorth reported 8% adjusted revenue growth for Pharmacy Benefit Services in the second quarter of 2026, to $34.496B from $31.954B.
Drug mix can lift revenue without higher claim volume
Cigna said the increase was driven primarily by claims composition, including the mix of branded, specialty, generic, and biosimilar drugs.
Pharmacy claim volume declined in the same quarter, so revenue growth should not be read as a pure utilization measure.
Adjusted revenue is an issuer-defined segment measure
The company reconciles adjusted revenue to reported revenue and uses it to evaluate segment performance.
Read it with pharmacy claim volume growth and PBM adjusted pre-tax income growth.
Primary source: Cigna Q2 2026 Form 10-Q.
Part of the Pharmacy Benefit & Specialty Care Economics
See It in Company Research
These companies are examples of how the concept is reported or discussed in public filings. Definitions can differ by issuer; these links open company research rather than a normalized metric comparison.
- CIOpen operating-model research →10 of 10 reviewed concepts in Pharmacy Benefit & Specialty Care EconomicsPBM versus specialty and care growth4 of 4 bridge concepts supportedContinue through this bridge:PBM Adjusted Pre-Tax Income GrowthSpecialty & Care Income GrowthSpecialty & Care Revenue Growth
Continue Research
Continue from the concept into the Grizzly Bulls research surface that best matches the next question. These links are research continuations, not recommendations or required steps.
Compare pharmacy services economics
Compare PBM adjusted revenue growth while separating drug mix from pharmacy claim volume.
Explore more topics in the Financial Research Encyclopedia.